These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 15055271)
21. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. Aldred MA; Vijayakrishnan J; James V; Soubrier F; Gomez-Sanchez MA; Martensson G; Galie N; Manes A; Corris P; Simonneau G; Humbert M; Morrell NW; Trembath RC Hum Mutat; 2006 Feb; 27(2):212-3. PubMed ID: 16429403 [TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Sztrymf B; Coulet F; Girerd B; Yaici A; Jais X; Sitbon O; Montani D; Souza R; Simonneau G; Soubrier F; Humbert M Am J Respir Crit Care Med; 2008 Jun; 177(12):1377-83. PubMed ID: 18356561 [TBL] [Abstract][Full Text] [Related]
23. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Atkinson C; Stewart S; Upton PD; Machado R; Thomson JR; Trembath RC; Morrell NW Circulation; 2002 Apr; 105(14):1672-8. PubMed ID: 11940546 [TBL] [Abstract][Full Text] [Related]
24. Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension. Elliott CG; Glissmeyer EW; Havlena GT; Carlquist J; McKinney JT; Rich S; McGoon MD; Scholand MB; Kim M; Jensen RL; Schmidt JW; Ward K Circulation; 2006 May; 113(21):2509-15. PubMed ID: 16717148 [TBL] [Abstract][Full Text] [Related]
25. [Study of the BMPR2 gene in patients with pulmonary arterial hypertension]. Portillo K; Santos S; Madrigal I; Blanco I; Paré C; Borderías L; Peinado VI; Roca J; Milà M; Barberà JA Arch Bronconeumol; 2010 Mar; 46(3):129-34. PubMed ID: 20096498 [TBL] [Abstract][Full Text] [Related]
26. Novel insertional mutation in the bone morphogenetic protein receptor type II associated with sporadic primary pulmonary hypertension. Sugiyama S; Hirota H; Yoshida M; Takemura Y; Nakaoka Y; Oshima Y; Terai K; Izumi M; Fujio Y; Hasegawa S; Mano T; Nakatsuchi Y; Hori M; Yamauchi-Takihara K; Kawase I Circ J; 2004 Jun; 68(6):592-4. PubMed ID: 15170098 [TBL] [Abstract][Full Text] [Related]
36. [Analysis of genetic mutation and modifier genes in pulmonary arterial hypertension]. Fujiwara M; Yagi H; Matsuoka R; Saji T Nihon Rinsho; 2008 Nov; 66(11):2071-5. PubMed ID: 19051722 [TBL] [Abstract][Full Text] [Related]
37. EIF2AK4 mutation as "second hit" in hereditary pulmonary arterial hypertension. Eichstaedt CA; Song J; Benjamin N; Harutyunova S; Fischer C; Grünig E; Hinderhofer K Respir Res; 2016 Nov; 17(1):141. PubMed ID: 27809840 [TBL] [Abstract][Full Text] [Related]
38. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. Harrison RE; Flanagan JA; Sankelo M; Abdalla SA; Rowell J; Machado RD; Elliott CG; Robbins IM; Olschewski H; McLaughlin V; Gruenig E; Kermeen F; Halme M; Räisänen-Sokolowski A; Laitinen T; Morrell NW; Trembath RC J Med Genet; 2003 Dec; 40(12):865-71. PubMed ID: 14684682 [TBL] [Abstract][Full Text] [Related]
39. Idiopathic pulmonary hypertension: what did we learn from genes? Sztrymf B; Yaïci A; Jaïs X; Sitbon O; Simonneau G; Humbert M Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S91-100. PubMed ID: 16457021 [TBL] [Abstract][Full Text] [Related]
40. Characterization of the BMPR2 5'-untranslated region and a novel mutation in pulmonary hypertension. Aldred MA; Machado RD; James V; Morrell NW; Trembath RC Am J Respir Crit Care Med; 2007 Oct; 176(8):819-24. PubMed ID: 17641158 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]